September 2004: Ultradent Products selects Vanguard Pharma as their partner in a dental salesforce expansion
Vanguard Pharma announces that it has been selected by Ultradent Products Inc., of the greater Salt Lake City, UT area to spearhead a promotional program in support of the recently launched whitening system Treswhite by Opalesence.

Tres white is the first whitening system to feature pre-filled, adaptable, and disposable whitening trays. There is no need for impressions, models, or lab time. The thin, comfortable tray easily adapts to fit the entire smile (not just the front six teeth), the delivery tray ensures easy placement by patients, and the protective gingival barrier gel (pre-filled) ensures comfort while whitening. Treswhite contains 9% hydrogen peroxide gel as its active ingredient. With two pleasant flavors, mint and melon, and the ease-of-use of Treswhite, patient acceptance of this product is very high.

"Vanguard Pharma is pleased to build on our dental sales experience from previous projects and partner with Ultradent in this exciting initiative. Initially, we will focus on selected geographical areas chosen by Ultradent to introduce and promote this unique product to the dental community, we look forward to contributing in a significant way to Treswhite sales" states Kevin Danylchuk, Vanguard Pharma's General Manager.

June 2004: Prestwick Pharmaceuticals selects Vanguard Pharma to become Canadian salesforce partner to promote Nitoman.
Prestwick Pharmaceuticals of Washington, DC selects Vanguard Pharma to become their partner in establishing and managing their Canadian salesforce operation. Under the terms of this agreement, Vanguard Pharma will supply Prestwick Pharmaceuticals with a CNS specialty salesforce that will serve to promote Nitoman, (tetrabenazine), an agent approved for the treatment of tardive dyskinesia and other movement disorders.

"We are very excited about this opportunity" proclaimed Jennifer Meldrum, Vanguard Pharma's Director of Client Services, "the salesforce efforts and experiences that will stem from our partnership will not only serve the Canadian market well, but provide great learning opportunites for Prestwick as they prepare to launch tetrabenazine in the US in the near future".

June 2003: Nastech Pharmaceutical Company sells Nascobal (R)(cyanocobalamin) to Questcor Pharmaceuticals, Vanguard Pharma salesforce contract promoting Nascobal continues "business as usual".

April 2003: Nastech Pharmaceuticals selects Vanguard Pharma to become its specialty salesforce promoting Nascobal (R) (cyancobalamin).
Vanguard Pharma, a leading pharmaceutical contract selling organization based in Mahwah, NJ, has announced that it has been selected by the Nastech Pharmaceutical Company of Bothell, WA, a leader in nasal drug delivery technology, to provide a specialty salesforce to promote Nascobal (R), a nasal gel formulation of Cyanocobalamin USP (Vitamin B-12).

"We are tremendously excited at this opportunity to essentially become Nastech's specialty salesforce" stated Kevin Danylchuk, General Manager, Vanguard Pharma. "Vanguard's sales managers and reprsentatives have a long history of promoting products to the gastroenterologist and this program leverages those established relationships. The initial emphasis will be to target those specialists who treat Inflammatory Bowel Disease (IBD) patients who have a compromised ability to absorb Vitamin B-12 through the gastrointestinal system. Nascobal's intranasal delivery form allows these patients to increase their Vitamin B-12 levels more easily and conveniently than through painful injections."

January 2003: VANGUARD SELECT launched!
Vanguard Pharma launches Vanguard Select: A Sales Recruitment Service for the Pharmaceutical Industry. "With our extensive roster of high quality pharmaceutical sales applicants from across the US and Canada, it is a natural and logical extension of Vanguard Pharma's pharmaceutical selling service to be able to offer the industry access to these applicants in order to satisfy their sales force recruitment, expansion and short-term placement needs." says Jennifer Meldrum, national sales/program manager of Vanguard Pharma. Vanguard Select is able to offer these representative placement services at rates far below that of the average pharmaceutical industry recruiter. For more information visit www.vanguardpharma.com or call 1.800.573.2031.

December, 2002: Vanguard Representatives to be Absorbed into Dimethaid HealthCare Sales.
Dimethaid Healthcare Inc. has received an approvable letter regarding the topical anti-inflammatory medication PENNSAID (diclofenac sodium/DMSO carrier). Vanguard representatives are poised to be absorbed into Dimethaid's field force upon final approval and launch of PENNSAID in the marketplace. Dimethaid previously contracted with Vanguard Pharma to recruit and place a national sales force on Dimethaid's behalf in anticipation of the launch of PENNSAID. The Vanguard representatives have been preparing for the launch of PENNSAID by engaging in a host of pre-launch activities that will set the stage for a successful launch of this novel product. For more information, visit http://www.dimethaid.com

October 2002: Vanguard Pharma subsidiary PHARMACOLLEGE officially launched.
Vanguard Pharma launches PharmaCollege , a service designed to help individuals launch a career in pharmaceutical sales. "The need for such a service was clear from the overwhelming demand for information and interest about sales careers in the pharmaceutical industry, and now, finally, prospective entrants into the pharmaceutical industry have a professional array of products and services to help them in this regards" reports Kevin Danylchuk, General Manager, Vanguard Pharma. PharmaCollege offers everything from books (both in print and downloadable) to individual career counseling and resume services to live seminars across the US and Canada as well as archived "distance learning" seminars.

Jennifer Meldrum, National Sales Manager, Vanguard Pharma, adds "Previous to PharmaCollege, prospective entrants into the pharmaceutical industry had a limited choice of products from "mom and pop" authors who were self-proclaimed "experts" in the field, today we are very pleased to offer a unique, full-service approach that has the backing of corporate resources and offers expertise from a variety of experienced industry managers". To learn more about these services, visit www.pharmacollege.com.

September 2002: Philips Sonicare selects Vanguard Pharma for Representative Placement Services
Vanguard contracts with Philips Sonicare division to provide representatives to serve the dental marketplace in selected territories. "We're pleased to add to our client roster Philips Sonicare, a dental products company, in order to assist them with the promotion of their Sonicare toothbrush." says Kevin Danylchuk, Vanguard Pharma's General Manager. He adds "The dental market has both interesting parallels and differences compared to the physician marketplace and we look forward to serving Philips as we help take their selling message to the dental community."

May 2002: Purdue Pharma selects Vangaurd Pharma for Representative Placement Services
Purdue Pharma (Pickering, Ontario) selects Vanguard Pharma to provide representatives in designated territories across Canada. Vanguard General Manager Kevin Danylchuk reports that "We are pleased to welcome Purdue Pharma 
to Vanguard's extensive list of pharmaceutical industry partners in helping them with their sales force needs - we look forward to working with Purdue."

January 2002: Allergan extends its contract representative program with Vanguard Pharma

August 2001: Dimethaid Healthcare Inc. chooses Vanguard Pharma to establish its pharmaceutical sales force.
Dimethaid Health Care selects Vanguard Pharma as its sales force partner in preparing for the approval and subsequent launch of its flagship product, the topical anti-inflammatory PENNSAID (diclofenac sodium/DMSO). "After an extensive review of possible partners, we're pleased to report that Vanguard Pharma was selected by Dimethaid Health Care because of Vanguard's unwavering commitment to quality, client service, and results as evidenced by our previous successful contracts with Solvay Pharma, Allergan, Glaxo Smith Kline, and other industry partners. The launch of PENNSAID will be an important new therapeutic option for arthritic patients and Vanguard Pharma is very pleased to be involved in such an exciting project." reports Kevin Danylchuk, General Manager, Vanguard Pharma.

February 2001: Block Drug Company selects Vanguard Pharma as its contract sales organization partner to promote the Sensodyne toothpaste product family
Block Drug Company selects Vanguard Pharma as its contract sales organization partner to promote the Sensodyne toothpaste product family and Atridox to the Canadian dental community via a national team of representatives.Jennifer Meldrum, National Sales Manager, Vanguard Pharma, reports "The purpose of this program is to lend extra sales support to Block, which has a growing product line and could benefit from additional sales personnel provided by Vanguard. We at Vanguard Pharma are particularly excited about this opportunity for it marks our introduction to the dental marketplace and we look forward to applying our learnings from the physician marketplace and working with dentists, dental hygienists, and other dental professionals to further support Sensodyne and other Block Drug products."

January 2001: Solvay Pharma absorbs selected Vanguard representatives into its internal Canadian salesforce.

January 2001: Solvay Pharma terminates Vanguard's long-running auxiliary sales force in favor of creation of a 2nd internal salesforce to support its newly acquired cardiovascular product line.